More traditional biomarkers like CEA, ProGRP, SCC, NSE, and CYFRA21-1 are commonly used for the diagnosis and management indicators of lung cancer (Mishra and Verma 2010; NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). The gene discussed is CEACAM5; the disease is lung cancer.